
Reganza-L Capsule SR
Manufacturer
Mediganza Healthcare
Salt Composition
Levosulpiride (75mg) + Rabeprazole (20mg)
Key Information
Short Description
Reganza-L Capsule SR is a prescription medicine used to treat gastroesophageal reflux disease (acid reflux), intestinal ulcers, and irritable bowel syndrome.
Dosage Form
Capsule SR
Introduction
Reganza-L Capsule SR is taken with or without food in a dose and duration as advised by the doctor. The dose you are given will depend on your condition and how you respond to the medicine. You should keep taking this medicine for as long as your doctor recommends. If you stop treatment too early your symptoms may come back and your condition may worsen. Let your healthcare team know about all other medications you are taking as some may affect or be affected by this medicine.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Reganza-L Capsule SR is to be taken empty stomach.
Safety Information
Side Effects
The most common side effects are nausea, stomach pain, diarrhea, flatulence, constipation, headache, weakness, and flu-like symptoms.
Alcohol Warning
It is unsafe to consume alcohol with Reganza-L Capsule SR.
Breastfeeding Warning
Information regarding the use of Reganza-L Capsule SR during breastfeeding is not available. Please consult your doctor.
Pregnancy Warning
Reganza-L Capsule SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
How it works
Reganza-L Capsule SR is a combination of two medicines: Levosulpiride and Rabeprazole.
Quick Tips
Do not consume alcohol while taking Reganza-L Capsule SR as it can increase the risk of stomach damage. Long-term use may cause weak or broken bones. Take adequate intake of dietary calcium and vitamin D or their supplements. Do not take Reganza-L Capsule SR for longer than prescribed.
Related Medicines

Rabonik Plus Capsule SR

Acera-L Capsule SR

Colosafe-L Capsule SR

Rablet L Capsules

Rabemac LS Capsule

Ansuper-Plus Capsule SR

Razo-L Capsule

Veloz L Capsule

R-Ppi-L Capsule SR

Rabimak L 75mg/20mg Capsule SR
Frequently asked questions
When should Reganza-L Capsule SR be taken?
Take Reganza-L Capsule SR exactly as directed by your doctor. The recommended dose is one capsule daily, which should be taken on an empty stomach to maximize absorption.
What conditions make it inadvisable to use Reganza-L Capsule SR?
Use of Reganza-L Capsule SR should be avoided in patients with a known allergy to any component or excipient of this medicine. Inform your doctor about any allergies before starting treatment.
Can dizziness occur as a side effect of taking Reganza-L Capsule SR?
Yes, some patients may experience dizziness (feeling faint, weak, unsteady, or lightheaded) while taking Reganza-L Capsule SR. If you feel dizzy, it is advisable to rest for a short time and resume once your symptoms have improved.
Is there an increased risk of fractures associated with the use of Reganza-L Capsule SR?
Several studies in adults suggest that treatment with high doses of Reganza-L Capsule SR may be associated with an increased risk of osteoporosis-related fractures, particularly of the hip, wrist, or spine. This risk is higher for patients receiving multiple daily doses and long-term therapy (a year or longer).
Can driving be safely resumed after taking Reganza-L Capsule SR?
No, taking Reganza-L Capsule SR may cause drowsiness, dizziness, or affect your eyesight. It is essential to wait until you know how this medicine affects you before resuming driving or operating machines.
What are the proper storage and disposal instructions for Reganza-L Capsule SR?
To maintain efficacy and safety, store Reganza-L Capsule SR in its original packet or container, tightly closed. Dispose of unused medicine according to local regulations, ensuring it does not come into contact with pets, children, or other individuals.